1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 19 JANUARY 2015

Cancer Drug News 19 JANUARY 2015

  • January 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Keytruda/Opdivo Competition To Intensify
Industry Brief - Amgen/MD Anderson Collaborate To Develop BiTE Therapies For MDS
Industry Brief - Solasia/Meiji Sign Japanese Darinaparsin Licensing Deal For PTCL
Industry Brief - Cellectis/Ohio State University Team Up To Develop CAR Technology For MM
Industry Brief - Actinium Initiates cGMP Manufacturing Of lomab-B For Phase III AML Trial
Industry Trend Analysis - Pfizer Heads Straight For Most Competitive Indication In Immuno-Oncology Market
Industry Brief - PharmaMar To Begin PM1183+Doxorubicin Phase III Trial In SCLC
Industry Brief - Tokai Signs Deals For Galeterone Companion Diagnostic
Industry Brief - Custirsen Phase III MCRPCA Trial To Continue Following IDMC Recommendation
Industry Brief - NantCell/Amgen Sign AMG 479 Licensing Deal For Cancer Therapy
Industry Brief - Merck/Lilly Enter Collaboration For Keytruda Combination Regimens
Industry Brief - 3SBio/PharmAbcine Sign DIG-KT Licensing Agreement
Industry Brief - Intrexon/ZIOPHARM/MD Anderson Sign CAR T Pact For Cancer Immnunotherapies
Industry Brief - Actavis Launches US Generic Speciality Injectable Portfolio
Industry Brief - OBT Licenses BI To Develop Antibody Products To Oncology Target
Industry Trend Analysis - UK Political Parties Provide Limited Options For A Sustainable Cancer Drugs Fund
Industry Brief - DelMar Granted US Patent Allowance For VAL-083
Industry Brief - Actavis Challenges US Abstral Patents
Industry Brief - Nuvilex Name Change To PharmaCyte Biotech
Industry Trend Analysis - Roche's Majority Stake In Foundation Medicine Will Bolster NGS Oncology Efforts

Table Of Contents

Cancer Drug News 19 JANUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


Download Unlimited Documents from Trusted Public Sources

Hepatitis Statistics and Therapy Market in the UK

  • March 2017
    10 pages
  • Hepatitis  

    Therapy  

    Antiviral  

  • United Kingdom  

View report >

Opioid Market in the US

  • March 2017
    13 pages
  • Opioid  

  • United States  

View report >

Glucagon Like Peptide 1 Receptor Activator Market

  • March 2017
    3 pages
  • Glucagon Like P...  

    Antidiabetics  

    Cardiology  

View report >

Diabetes Statistics

4 days ago

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.